Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multifunctional Polymer Neutralizes both Biological and Chemical Weapons

By LabMedica International staff writers
Posted on 14 Apr 2010
In an ongoing effort to mimic the ability of biological tissues to respond quickly and appropriately to changing environments, researchers have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. More...


Investigators from the University of Pittsburgh McGowan Institute for Regenerative Medicine (Pittsburgh, PA, USA) described the findings online March 2, 2010, in the journal Biomaterials. "Our lab applies biological principles to create materials that can do many things, just like our skin protects us from both rain and sun,” said senior investigator Alan Russell, Ph.D., university professor of surgery, University of Pittsburgh School of Medicine (UPMC), and director, McGowan Institute, a joint effort of the university and UPMC. "Typically, labs engineer products that are designed to serve only one narrow function.”

Those traditional approaches might not provide the best responses for weapons of mass destruction, which could be biological, such as smallpox virus, or chemical, such as the nerve agent sarin, Dr. Russell noted. Terrorists are not going to announce what kind of threat they unleash in an attack. "That uncertainty calls for a single broad-spectrum decontamination material that can rapidly neutralize both kinds of threats and is easily delivered or administered, and it must not damage the environment where it is applied,” he said. "Much work has gone into developing ways to thwart either germ or chemical weapons, and now we're combining some of them into one countermeasure.”

Dr. Russell and his team have devised a polyurethane fiber mesh containing enzymes that lead to the production of bromine or iodine, which kill bacteria, as well as chemicals that generate compounds that detoxify organophosphate nerve agents.

"This mesh could be developed into sponges, coatings or liquid sprays, and it could be used internally or as a wound dressing that is capable of killing bacteria, viruses and spores,” said lead investigator Gabi Amitai, Ph.D., of the McGowan Institute and the Israel Institute for Biological Research (IIBR; Ness-Ziona). "The antibacterial and antitoxin activities do not interfere with each other, and actually can work synergistically.”

In their experiments, the material fended off Staphylococcus aureus and Escherichia coli, which represent different classes of bacteria. After 24 hours, it restored 70% of the activity of acetylcholinesterase, an enzyme that is inhibited by nerve agents leading to fatal dysfunction of an essential neurotransmitter.

The researchers reported that they are continuing to develop alternate decontamination strategies to address chemical and biologic weapons.

The McGowan Institute for Regenerative Medicine was established by the University of Pittsburgh School of Medicine and its clinical partner, UPMC, to realize the vast potential of tissue engineering and other techniques aimed at repairing damaged or diseased tissues and organs. The McGowan Institute serves as a single base of operations for the university's leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, biosurgery and artificial and biohybrid organ devices.

Related Links:

McGowan Institute for Regenerative Medicine
Israel Institute for Biological Research



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.